Tumour Marker Panel — Men

A blood panel measuring four tumour markers relevant to men, intended as a screening adjunct rather than a diagnostic test on its own. For 160 zł it covers PSA, AFP, CA 19-9 and CEA. It may be chosen by men wanting these markers — including PSA — checked as part of broader monitoring or because of family history. Tumour-marker results are non-specific and are always interpreted by a physician alongside other findings.

The Tumour Marker Panel for men measures four blood markers — PSA (prostate-specific antigen), AFP (alpha-fetoprotein), CA 19-9 and CEA (carcinoembryonic antigen) — packaged together at 160 zł as a convenient way to have them assessed in one draw. PSA in particular is widely recognised in the context of prostate health monitoring. As with all tumour-marker testing, these proteins are non-specific: levels can be influenced by benign conditions, and a single result — whether normal or raised — does not on its own confirm or rule out disease. The panel is therefore offered as a screening adjunct rather than a standalone diagnosis, and the results are intended to be interpreted by a physician alongside your history, symptoms, examination and any imaging. Men often choose it as part of broader preventive monitoring, because of a relevant family history, or where a clinician wishes to follow these values over time; PSA results especially benefit from being read in context and tracked as a trend rather than a one-off number. Blood is taken at the al. Wyzwolenia 7 collection point on a weekday morning and processed via Pramed's ALAB laboratoria partnership. The package can be bought directly without a referral, but reviewing the findings with one of the clinic's physicians — for example in urology or internal medicine — is strongly recommended so the results are understood properly and any sensible follow-up arranged.